Skip to main content
Log in

Forced Degradation Study to Develop and Validate Stability-Indicating RP-LC for Quantification of Ropinirole Hydrochloride in Its Modified Release Tablets

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A forced degradation study on ropinirole hydrochloride in bulk and in its modified release tablets was conducted under the conditions of hydrolysis, oxidation and photolysis in order to develop an isocratic stability-indicating LC-UV method for quantification of the drug in tablets. An impurity peak in standard solution was found to increase under acidic and neutral hydrolytic conditions while another degradation product was formed under alkaline condition. The drug and its degradation products were optimally resolved on a Hypersil C18 column with mobile phase composed of diammonium hydrogen orthophosphate (0.05 M; pH 7.2), tetrahydrofuran and methanol (80:15:5% v/v) at a flow rate of 1.0 mL min−1 at 30 °C using 250 nm as detection wavelength. The method was linear in the range of 0.05–50 μg mL−1 drug concentrations. The %RSD of inter- and intra-day precision studies was <1. The system suitability parameters remained unaffected during quantification of the drug on three different LC systems. Excellent recoveries (101.59–102.28%) proved that the method was sufficiently accurate. The LOD and LOQ were found to be 0.012 and 0.040 μg mL−1, respectively. Degradation behaviour of the drug in both bulk and tablets was similar. The drug was very unstable to hydrolytic conditions but stable to oxidative and photolytic conditions. The method can be used for rapid and accurate quantification of ropinirole hydrochloride in tablets during stability testing. Based on chemical reactivity of ropinirole in different media, the degradation products were suspected to be different from the known impurities of the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kurzel MD (1999) Am J Health Syst Pharm 56:217–224

    Google Scholar 

  2. Rascol O, Lees AJ, Senard JM (1996) Clin Neuropharmacol 19:234–245

    Article  CAS  Google Scholar 

  3. Matsukawa N, Maki M, Yasuhara T, Hara K, Yu G, Xu L et al (2007) Brain Res 1160:113–123. doi:10.1016/j.brainres.2007.05.030

    Article  CAS  Google Scholar 

  4. Brooks DJ, Abbott RJ, Lees AJ (1998) Clin Neuropharmacol 2:101–107

    Google Scholar 

  5. March J (1992) Advanced Organic Chemistry. Reactions, mechanisms and structure, 4th edn. Wiley-Interscience, New York, pp 383–386

    Google Scholar 

  6. Challis BC, Challis JA (1970) Reactions of the carboxamide group. In: Zabicky IJ (ed) The Chemistry of Amides: Reactions of the carboxamide group. Intersciences Publisher, London, pp 731–857

    Google Scholar 

  7. Lwowski W (1984) Reactivity of small and large rings. In: Lwowski W (ed) Comprehensive heterocyclic chemistry. The structure, reactions, synthesis and uses of heterocyclic compounds. Pergamon Press, Oxford, pp 17–29

    Google Scholar 

  8. ICH (2003) Stability testing of new drug substances and products. In: International conference on harmonization, IFPMA, Geneva

  9. ICH (2006) Impurities in new drug substances. In: International conference on harmonization, IFPMA, Geneva

  10. ICH (2006) Impurities in new drug products. In: International conference on harmonization, IFPMA, Geneva

  11. Susheel JV, Malathi S, Ravi TK (2007) Indian J Pharm Sci 69:589–591

    Article  CAS  Google Scholar 

  12. Aydogmus Z (2008) Spectrochim Acta A Mol Biomol Spectrosc 70:69–78. doi:10.1016/j.saa.2007.07.012

    Article  CAS  Google Scholar 

  13. Swagzdis J, Mico B (1986) J Pharm Sci 75:90–91. doi:10.1002/jps.2600750122

    Article  CAS  Google Scholar 

  14. Onal A (2006) Chromatographia 64:459–461. doi:10.1365/s10337-006-0045-1

    Article  CAS  Google Scholar 

  15. Bhatta J, Jangida A, Shettya R, Shaha B, Kamblia S, Subbaiaha G et al (2006) J Pharm Biomed Anal 40:1202–1208. doi:10.1016/j.jpba.2005.09.024

    Article  CAS  Google Scholar 

  16. Coufal P, Stulík K, Claessens HA, Hardy MJ, Webb M (1999) J Chromatogr B Biomed Sci Appl 732:437–444. doi:10.1016/S0378-4347(99)00314-X

    Article  CAS  Google Scholar 

  17. Sahasrabuddheya B, Nautiyala R, Acharyab H, Khyadea S, Luthrab PK, Deshpande PB (2007) J Pharm Biomed Anal 43:1587–1593. doi:10.1016/j.jpba.2006.11.030

    Article  CAS  Google Scholar 

  18. ICH (1996) Photostability testing of new drug substances and products. In: International conference on harmonization, IFPMA, Geneva

  19. ICH (2005) Validation of analytical procedures: Text and methodology. In: International conference on harmonization, IFPMA, Geneva

  20. Bakshi M, Singh S (2002) J Pharm Biomed Anal 28:1011–1040. doi:10.1016/S0731-7085(02)00047-X

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors are thankful to Prof. Bhupinder Singh Bhoop, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh (India) and to Dr. R. K. Goel, Ms. Dimple Chopra and Ms. Kanchan Vohra, Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala (India) for their timely help in statistical evaluation of the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gulshan Bansal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parmar, G., Sharma, S., Singh, K. et al. Forced Degradation Study to Develop and Validate Stability-Indicating RP-LC for Quantification of Ropinirole Hydrochloride in Its Modified Release Tablets. Chroma 69, 199–206 (2009). https://doi.org/10.1365/s10337-008-0866-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-008-0866-1

Keywords

Navigation